RISK FACTORS, TREATMENT STRATEGIES, AND OUTCOMES OF ENDOPHTHALMITIS ASSOCIATED WITH SEVERE FUNGAL KERATITIS

Retina
Lei WanLixin Xie

Abstract

To investigate risk factors, treatment strategies, and outcomes of endophthalmitis associated with severe fungal keratitis. Data from 392 patients diagnosed with fungal keratitis were retrospectively examined. Patients had severe disease that was refractory to topical or systemic antifungal therapy, and the infection involved the endothelium or perforated the cornea. The incidence and risk factors for endophthalmitis, and treatment outcomes were evaluated. Thirty-seven of 392 patients (9.4%) had endophthalmitis. Multivariate logistic regression revealed the following risk factors for endophthalmitis: topical steroid use (odds ratio [OR] = 6.35, 95% confidence interval [CI]: 2.01-20.08), previous corneal laceration suturing (OR = 5.05, 95% CI: 1.11-22.93), large corneal ulcer size (≥10-mm diameter; OR = 4.43, 95% CI: 1.71-11.50), hypopyon (OR = 11.05, 95% CI: 2.12-57.55), and aphakia (OR = 15.45, 95% CI: 1.59-149.82). Thirty of the 37 eyes (81.1%) with endophthalmitis were saved by penetrating keratoplasty, vitrectomy, or intravitreal antifungal injection; 7 eyes (18.9%) were eviscerated. Most patients with endophthalmitis secondary to corneal fungal infection were successfully managed by penetrating keratoplasty, vitrectomy, or...Continue Reading

References

Nov 1, 1996·Ophthalmology·I U ScottD Miller
Aug 25, 2001·The British Journal of Ophthalmology·L XieW Shi
Jun 7, 2003·Cornea·Dilek DursunEduardo C Alfonso
Aug 29, 2006·Ophthalmology·Lixin XieShiying Sun
Jun 26, 2007·Ophthalmology·Lixin XieWeiyun Shi
Sep 4, 2008·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·C LangeM Bach
Dec 17, 2009·Ophthalmology·Ali A ZaidiUNKNOWN Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study
Jun 14, 2013·Journal of Ophthalmic Inflammation and Infection·Christopher R HenryEduardo C Alfonso
Jul 18, 2014·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Evelyn C O'NeillPaul P Connell
Jun 28, 2016·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Ting WangWeiyun Shi
Jul 19, 2016·Retina·Mehrdad MalihiNeelakshi Bhagat

❮ Previous
Next ❯

Citations

Mar 6, 2019·European Journal of Ophthalmology·Meng-Yang LiuShi-Ying Sun
Jul 10, 2019·Acta Anaesthesiologica Scandinavica·Magnus LjunggrenSnejana Hyllén
Jul 28, 2019·International Journal of Molecular Sciences·Ming-Tse KuoHuey-Ling You
May 29, 2021·Scientific Reports·Dhanach DhirachaikulpanichPitipol Choopong
Jul 14, 2021·Ocular Immunology and Inflammation·Imen KsiaaMoncef Khairallah
Nov 28, 2021·Journal of Fungi·Abid A HaseebAhmed B Sallam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.